• Latest Posts

Innovative Eye Disease Therapies Move Closer to the Clinic

First Gene Therapy for Inherited Blindness Approved in Europe

Interview 3 Sep 2018

Moving from Big Pharma to Biotech – Insights from Two Biotech CEOs

The First CAR-T Therapy Is Not Living Up to Commercial Expectations

Is Novartis’ Psoriasis Drug Going to Steal Humira’s Crown?

ADVERTISEMENT
In Depth 25 Jan 2018

What Happened to the Plans for a Smart Contact Lens for Diabetics?

Novartis Takes Genmab’s Leukemia Drug Off the Market

The FDA Approves the First CAR-T Cell Therapy for Cancer

Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks

Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns

ADVERTISEMENT